natco pharma shares climbed over 11% on february 16 after receiving approval to launch semaglutide in india. semaglutide is used to manage chronic weight and treat type-2 diabetes."natco pharma limited received approval for semaglutide from cdsco to manufacture and market generic semaglutide injection in india. natco will launch the product in the india market in march 2026. semaglutide is indicated for the treatment of adults with insufficiently

shares of national aluminium company declined by 2.12% to rs 341.90 at 10:45 am. this marks a notable movement for the stock, which is a constituent of the nift

in monday's trading session, several stocks demonstrated significant gains, with gmr airports and crisil leading the nifty midcap 150 index. at 10:30 am, gmr ai

shares of astral limited reached a 52-week high of rs 1,615.00 on the nse on monday, marking a 1.16% increase from the previous close. the company's financial p

the shares of ola electric mobility tumbled nearly 7 percent on february 16 after the company released its results for the october-december quarter of the ongoi

the benchmark indices dropped 1.3 percent on ai-led disruption fears on february 13, with consistent weakness in market breadth. about 2,272 shares were under p

let's catch up on the latest news from the stock market. from significant investments to major deals, quarterly earnings, order wins, and acquisitions, here’s

lupin ltd. posted a 37.4 per cent year-on-year (yoy) jump in quarterly net profit to rs. 1,180.5 crore in q3 fy26, driven primarily by record us sales, stronger

the it index fell for its third straight session on february 13 by declining a whopping 5% on intensifying fears of ai-driven automation disrupting indian it's

equity benchmarks fell around 0.6 percent after a four-day winning streak, with market breadth weakening further on february 12. a total of 1,909 shares were un